Week51, 2022
1. Influenza activity is elevated and continues to increase, with 16.1% of tested specimens positive for influenza.
2. Public health labs report 85.5% of viruses as Influenza A, with A(H1N1)pdm09 predominant at 79%, and Influenza B accounting for 14.5%.
3. The cumulative hospitalization rate is 15.4 per 100,000, with higher rates among older adults and children under 4.
4. Influenza-associated deaths rose to 0.5%, and seven pediatric deaths were reported this week, primarily linked to Influenza A(H1N1).
5. Outpatient respiratory illness visits accounted for 6.1%, remaining above baseline for eight consecutive weeks.
6. Weekly flu hospitalizations (14,732) increased by >5% nationally compared to the previous week.
7. Since October 2023, flu has caused 4,500 deaths, 73,000 hospitalizations, and 7.1 million illnesses in the U.S.
8. Vaccination is recommended for all aged 6 months and older; no significant new vaccination trends noted.
9. CDC highlights co-circulation of influenza, COVID-19, and RSV, with integrated reporting for respiratory illnesses.
10. Genetic and antigenic analysis of circulating influenza viruses shows good vaccine compatibility, though reduced oseltamivir susceptibility was observed in one A(H1N1)pdm09 virus.
11. Regional variations include high positivity in regions 3, 4, 6, and 8, with Influenza A remaining dominant.
12. CDC expects flu activity to continue rising in the near term; respiratory illness patterns indicate significant public health impacts.